Evidence map›Paper›PMID 39575018›Full record

ArticleCureus2024

A Case of Type 1 Diabetes Mellitus With Intractable Chronic Diarrhea and Challenging Glycemic Control.

Shoko M Yamada, Hitomi Takada, Takane Harada, Shozo Terada, Yoshio Nehashi, Noriko Mori

Abstract readCase Reports
In one paragraph

Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shoko M YamadaNeurosurgery, Teikyo University Hospital, Mizonokuchi, Kawasaki, JPN.
Hitomi TakadaInternal Medicine, JCHO Sakuragaoka Hospital, Shizuoka, JPN.
Takane HaradaInternal Medicine, JCHO Sakuragaoka Hospital, Shizuoka, JPN.
Shozo TeradaInternal Medicine, JCHO Sakuragaoka Hospital, Shizuoka, JPN.
Yoshio NehashiInternal Medicine, JCHO Sakuragaoka Hospital, Shizuoka, JPN.
Noriko MoriInternal Medicine, JCHO Sakuragaoka Hospital, Shizuoka, JPN.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The first step in treating diabetes mellitus (DM)-related diarrhea is to thoroughly control the serum glucose level. The authors herein describe a 75-year-old man who was diagnosed with type 1 DM when he was 32 years old. The patient lost his appetite due to hot weather and spent a week eating sweets and drinking juice. As a result, he developed diabetic ketoacidosis and was initially treated in another hospital, and then transferred to our facility for glycemic control two weeks later. He had been suffering from watery diarrhea for more than 100 days after being admitted to our hospital. His blood glucose control was extremely difficult, fluctuating between 30 and 500 mg/dL while watery diarrhea continued, and microscopic colitis was diagnosed by histological examination through endoscopy. Despite the use of insulin, multiple antidiarrheal agents including salazosulfapyridine, and a switch to total parenteral nutrition, his blood glucose fluctuations did not improve. In addition, his liver function deteriorated, his renal function declined, and hypoproteinemia developed. Considering drug-induced liver dysfunction, steroids were administered despite the high risk of further poor glycemic control. Following steroid administration, his liver function rapidly improved and the watery diarrhea resolved within a few days. Contrary to our concerns, his blood glucose level stabilized between 100 and 200 mg/dL. The mechanism underlying the stabilization of blood glucose levels after steroid use remains unclear. Prior to steroid administration, the frequency of diarrhea had been reduced from more than five times a day to only once or twice a day with antidiarrheal agents; nevertheless, the patient's glycemic control worsened. Therefore, the stabilization of his blood glucose cannot simply be attributed to the resolution of the diarrhea. This case suggests that steroid administration may be a consideration in patients with DM-related watery diarrhea who show a poor response to antidiarrheal agents and severe blood glucose fluctuations.

Indexed as

antidiarrheal agentsdiabetes mellitusdiarrheaglycemic controlsteroids

Identifiers

PMID39575018
PMCPMC11578860

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.